STOCK MARKET BSE NSE

COVID crisis: Maharashtra to set up control rooms for smooth supply of Remdesivir

Remdesivir is considered a key medicine in the fight against COVID-19, especially in adult patients with severe complications.

Published: 11th April 2021 01:16 PM  |   Last Updated: 11th April 2021 01:16 PM   |  A+A-

A bottle containing the drug Remdesivir is held by a health worker at the Institute of Infectology of Kenezy Gyula Teaching Hospital

A bottle containing the drug Remdesivir is held by a health worker. (Photo | AP)

By PTI

MUMBAI: The Maharashtra government has decided to set up district-level control rooms to ensure smooth supply of Remdesivir injections and prevent hoarding and black-marketing of the drug, officials said on Sunday.

Remdesivir is considered a key medicine in the fight against COVID-19, especially in adult patients with severe complications.

The state is facing multiple issues pertaining to the drug, like demand-supply gap, its hoarding and black-marketing by stockists and pharmacy shops, unaffordable prices and irrational prescription by some doctors.

Maharashtra's health services commissioner Ramaswami N, in a letter dated April 9, has written to all district collectors in the state to set up control rooms to streamline the supply of the key anti-viral drug.

ALSO READ | Maharashtra COVID-19 crisis: Gadkari dials Sun Pharma chief amid Remdesivir shortage in Nagpur 

Chief Minister Uddhav Thackeray recently reviewed the situation with state Health Minister Rajesh Tope, Medical Education Minister Amit Deshmukh, Food and Drug Administration (FDA) Minister Rajendra Shingne and Urban Development Minister Eknath Shinde.

The government has asked authorities to cap the price of Remdesivir between Rs 1,100 and Rs 1,400 per vial and urged about a dozen pharmaceutical companies manufacturing the drug to ramp-up its production and lower its MRP (maximum retail price).

It has also asked the health services commissioner to put in place a separate mechanism to streamline the supply of Remdesivir, in the wake of a rise in its demand due to a surge in COVID-19 cases.

Ramaswami, who is also the state's mission director of the National Health Mission, has directed the FDA to contact the state-level control room and take appropriate action, if needed, in case of any issue regarding the supply of the medicine.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp